These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27240535)

  • 1. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.
    Cipriani A; Saunders K; Attenburrow MJ; Stefaniak J; Panchal P; Stockton S; Lane TA; Tunbridge EM; Geddes JR; Harrison PJ
    Mol Psychiatry; 2016 Oct; 21(10):1324-32. PubMed ID: 27240535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel antagonists for the treatment of bipolar disorder.
    Levy NA; Janicak PG
    Bipolar Disord; 2000 Jun; 2(2):108-19. PubMed ID: 11252650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nimodipine in treatment of bipolar disorder].
    Romanov DV; Sheyanov AM; Samsonova MD; Iuzbashian PG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):20-26. PubMed ID: 38147378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel antagonists and the treatment of migraine.
    Greenberg DA
    Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.
    Ostacher MJ; Iosifescu DV; Hay A; Blumenthal SR; Sklar P; Perlis RH
    Bipolar Disord; 2014 Mar; 16(2):199-203. PubMed ID: 24372835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study.
    Atkinson LZ; Colbourne L; Smith A; Harmer CH; Nobre AC; Rendell J; Jones H; Hinds C; Mould A; Tunbridge EM; Cipriani A; Geddes JR; Saunders KEA; Harrison PJ
    Trials; 2019 Feb; 20(1):120. PubMed ID: 30755265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-type calcium channels and psychiatric disorders: A brief review.
    Casamassima F; Hay AC; Benedetti A; Lattanzi L; Cassano GB; Perlis RH
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1373-90. PubMed ID: 20886543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].
    Sarfati Y; Spadone C; Vanelle JM; Lôo H
    Encephale; 1996; 22(2):149-53. PubMed ID: 8706625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding.
    Keers R; Farmer AE; Aitchison KJ
    Psychol Med; 2009 Aug; 39(8):1231-5. PubMed ID: 19215628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses.
    Daschil N; Humpel C
    Brain Res; 2014 Sep; 1581():1-11. PubMed ID: 25038562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):35-47. PubMed ID: 30558453
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms.
    McCarthy MJ; Le Roux MJ; Wei H; Beesley S; Kelsoe JR; Welsh DK
    Neuropharmacology; 2016 Feb; 101():439-48. PubMed ID: 26476274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial.
    Janicak PG; Sharma RP; Pandey G; Davis JM
    Am J Psychiatry; 1998 Jul; 155(7):972-3. PubMed ID: 9659868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness.
    Davanzo PA; Krah N; Kleiner J; McCracken J
    J Child Adolesc Psychopharmacol; 1999; 9(1):51-61. PubMed ID: 10357518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000206. PubMed ID: 10796323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists in mania: a double-blind study of verapamil.
    Dubovsky SL; Franks RD; Allen S; Murphy J
    Psychiatry Res; 1986 Aug; 18(4):309-20. PubMed ID: 3529151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy.
    Yingling DR; Utter G; Vengalil S; Mason B
    Am J Obstet Gynecol; 2002 Dec; 187(6):1711-2. PubMed ID: 12501088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of verapamil in mania crises].
    Mathis P; Schmitt L; Moron P
    Encephale; 1988; 14(3):127-32. PubMed ID: 3402380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease.
    Anekonda TS; Quinn JF; Harris C; Frahler K; Wadsworth TL; Woltjer RL
    Neurobiol Dis; 2011 Jan; 41(1):62-70. PubMed ID: 20816785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.